Advertisements

Stocking Stuffers

 

Hemostemix Inc. (HEM:CA) Stock Quote

Detailed Quote for Hemostemix Inc (HEM:CA)
$ 0.075 0.00 (0.00%) Volume: 0 4:00 PM EDT 21-Mar-2019
Today 5d 1m 3m 1y more
Last Price
0.075
Change $
Change %
Tick
  
Bid
0.075
Bid Size
38,000
Ask
0.08
Ask Size
76,000
Open
N/A
High
N/A
Low
N/A
Prev Close
0.075
Last Trade
03/21/19
Volume
0
52 Wk Hi
0.14
52 Wk Low
0.05
Market Cap
22.57m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
300,898,610
EPS (TTM)
-0.009999999
PE Ratio
N/A
Exchange
TSXV
News and Media for Hemostemix Inc (HEM:CA)
Sector News | Topic News
News for Hemostemix Inc (HEM:CA)
Mon, Feb 25, 2019
8:30 AM Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial - GlobeNewswire
Mon, Feb 04, 2019
8:30 AM Hemostemix Announces Submission of Orphan Drug Designation Application to the FDA - GlobeNewswire
Thu, Jan 17, 2019
8:30 AM Hemostemix Provides Highlights of 2018 Accomplishments - GlobeNewswire
Thu, Jan 10, 2019
7:45 AM Today's Research Reports on Hemostemix, Fennec Pharmaceuticals, Sernova and Covalon Technologies - ACCESSWIRE IA
Thu, Jan 03, 2019
8:00 AM Hemostemix Announces Two Additional Sites Enrolled in Phase II Clinical Trial - GlobeNewswire
Wed, Nov 21, 2018
7:45 AM Today's Research Reports on Microbix Biosystems, Hemostemix, DiaMedica Therapeutics and Nuvo Pharmaceuticals - ACCESSWIRE IA
Fri, Nov 09, 2018
8:30 AM Hemostemix Announces Development of an ACP-01 Allogeneic Process and Initiation of R&D for Autologous NCP-01 Neural Cellular Precursors - GlobeNewswire
Thu, Nov 08, 2018
8:30 AM Hemostemix Announces Important Manufacturing Process Refinements - GlobeNewswire
Tue, Oct 30, 2018
9:07 AM Hemostemix Announces OTCQB Listing and DTC Eligibility - GlobeNewswire
Thu, Oct 25, 2018
8:00 AM Today's Research Reports on CardioComm Solutions, Sernova, Hemostemix and DiaMedica Therapeutics - ACCESSWIRE IA
Tue, Oct 09, 2018
8:30 AM Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial - GlobeNewswire
Thu, Sep 27, 2018
8:30 AM Hemostemix Announces Voting Results of the Annual and Special Meeting of Shareholders - GlobeNewswire
Mon, Sep 24, 2018
8:30 AM Hemostemix Announces Addition to Its Clinical Trial Management Team - GlobeNewswire
Tue, Sep 18, 2018
8:00 AM Today's Research Reports on Hemostemix, TSO3, Emerald Health Therapeutics and DiaMedica Therapeutics - ACCESSWIRE IA
Wed, Aug 22, 2018
8:00 AM Today's Research Reports on Centric Health, Hemostemix, CardioComm Solutions and Nuvo Pharmaceuticals - ACCESSWIRE IA
Thu, Aug 16, 2018
8:30 AM Hemostemix Announces Two New Strategic Trial Sites in Texas - GlobeNewswire
Mon, Jul 23, 2018
8:00 AM Today's Research Reports on Hemostemix, Cotinga Pharmaceuticals, Emerald Health Therapeutics and DiaMedica Therapeutics - ACCESSWIRE IA
Wed, Jul 18, 2018
8:30 AM Hemostemix Announces First U.S. Patients Treated in Phase II Clinical Trial - GlobeNewswire
Thu, Jul 05, 2018
8:29 AM Hemostemix Formalizes World-Class Scientific Advisory Board - GlobeNewswire
Fri, Jun 22, 2018
8:00 AM Today's Research Reports on Hemostemix, Cotinga Pharmaceuticals, Aurinia Pharmaceuticals and Baylin Technologies - ACCESSWIRE IA
More News for HEM:CA >>

Tags for Hemostemix Inc.

Research stocks or mutual funds related to Hemostemix Inc. by keywords or tags. Find companies that have a similar focus to HEM:CA. The keywords below have been associated to HEM:CA by either user submission or electronic means.

All Other Electrical Equipment and Component Manufacturing (335990) Other Instruments and Related Products Industry (3912) Telecommunication Carriers Industry (4821) Consumer Goods Common Stock Other Communication and Electronic Equipment Industries (3359) Consumer Durables